These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12807348)

  • 41. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P
    J Clin Epidemiol; 2003 Apr; 56(4):367-76. PubMed ID: 12767414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
    Imbimbo BP
    CNS Drugs; 2001; 15(5):375-90. PubMed ID: 11475943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract.
    Solfrizzi V; Panza F
    J Alzheimers Dis; 2015; 43(2):605-11. PubMed ID: 25352453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
    Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M;
    Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
    Chen X; Hong Y; Zheng P
    Psychiatry Res; 2015 Jul; 228(1):121-7. PubMed ID: 25980333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of a Ginkgo biloba extract.
    Le Bars PL; Kastelan J
    Public Health Nutr; 2000 Dec; 3(4A):495-9. PubMed ID: 11276297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial.
    McCarney R; Fisher P; Iliffe S; van Haselen R; Griffin M; van der Meulen J; Warner J
    Int J Geriatr Psychiatry; 2008 Dec; 23(12):1222-30. PubMed ID: 18537221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761].
    Haan J; Hörr R
    Wien Med Wochenschr; 2004 Nov; 154(21-22):511-4. PubMed ID: 15638069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting.
    Rainer M; Mucke H; Schlaefke S
    Wien Klin Wochenschr; 2013 Jan; 125(1-2):8-15. PubMed ID: 23292640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S
    J Psychiatr Res; 2012 Jun; 46(6):716-23. PubMed ID: 22459264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Galantamine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004746. PubMed ID: 16437493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis.
    Wang BS; Wang H; Song YY; Qi H; Rong ZX; Wang BS; Zhang L; Chen HZ
    Pharmacopsychiatry; 2010 May; 43(3):86-91. PubMed ID: 20104449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug therapies for cognitive impairment and dementia.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Apr; 48(4):11-4. PubMed ID: 20349884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of drugs against dementia on cognition in aging and mild cognitive impairment.
    Ihl R
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S38-43. PubMed ID: 13130387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategies for the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Chan YF; Chen C; Dasig D; Dominguez J; Han SH; Jia J; Kim S; Limpawattana P; Ng LL; Nguyen DT; Ong PA; Raya-Ampil E; Saedon N; Senanarong V; Setiati S; Singh H; Suthisisang C; Trang TM; Turana Y; Venketasubramanian N; Yong FM; Youn YC; Ihl R
    CNS Neurosci Ther; 2021 Feb; 27(2):149-162. PubMed ID: 33352000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
    Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus.
    Morgenstern C; Biermann E
    Int J Clin Pharmacol Ther; 2002 May; 40(5):188-97. PubMed ID: 12051570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.
    Ihl R; Tribanek M; Bachinskaya N
    J Neurol Sci; 2010 Dec; 299(1-2):184-7. PubMed ID: 20837354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.